Clinical Trials Browser

Withdrawn × pazopanib × Gynecologic × Clear all

NCT02348398 2016-08-16

Phase II Study of Pazopanib and Topotecan in Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms